Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Faculty of Medicine

7 abstracts

Abstract
Overall survival analysis from the ADAURA trial of adjuvant osimertinib in patients with resected EGFR‑mutated (EGFRm) stage IB–IIIA non-small cell lung cancer (NSCLC).
Org: Medical Oncology, Yale School of Medicine, Yale Cancer Center, Department of Thoracic Surgery and Oncology, National Cancer Center Hospital East, Kashiwa, Japan,
Abstract
Results of a tailored multimodal lifestyle follow-up care program focusing on physical activity, nutritional behavior and psychological processes in adolescent and young adult cancer survivors: The CARE for CAYA multicenter, randomized clinical trial.
Org: University Cancer Center Hamburg, Universitätsklinikum Hamburg-Eppendorf, University Hospital Bonn, Department of Internal Medicine I, Medical University of Vienna, Campus Luebeck,
Abstract
Tolerability and efficacy of BrECADD versus BEACOPP in advanced stage classical Hodgkin lymphoma: GHSG HD21, a randomized study.
Org: University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), German Hodgkin Study Group (GHSG), Swiss Group for Clinical Cancer Research (SAKK), Department of Internal Medicine III with Hematology,
Abstract
CD8 radiomics signature to assess inter-lesion spatial heterogeneity and cold liver lesions in advanced non-small cell lung cancers treated with durvalumab.
Org: Gustave Roussy Cancer Center, Department of Radiation Oncology, Université Paris-Saclay, UMR 1030, ImmunoRadAI,
Abstract
Association between comorbidity clusters and mortality in patients with cancer: A machine learning analysis of data from the US National Health and Nutrition Examination Survey 1999–2018.
Org: School of Pharmacy and Pharmaceutical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Sanatorium & Hospital, China National Biotec Group,
Abstract
MANCAN2: A multicentre randomised controlled trial of self-help cognitive behavioural therapy (CBT) to manage hot flush and night sweats (HFNS) symptoms in patients with prostate cancer receiving androgen deprivation therapy (ADT).
Org: Southampton Clinical Trials Unit, University of Southampton, University Hospital Southampton NHS Foundation Trust, Turning Point Therapeutics, Guys and St Thomas NHS Foundation Trust,
Abstract
Atezolizumab versus placebo in combination with bevacizumab and non-platinum-based chemotherapy in recurrent ovarian cancer: Final overall and progression-free survival results from the AGO-OVAR 2.29/ENGOT-ov34 study.
Org: GEICO, Arcagy-Gineco, NSGO-CTU, SAKK, BGOG,